The global pericardial patches market was valued at USD 336.8 million in 2024 and is likely to value at USD 777.9 million by 2037, increasing at a CAGR of around 6.6% from 2025 to 2037. This reflects strong demand across various surgical applications, mainly for cardiovascular procedures. The demand for pericardial patches is likely to rise at a steady pace owing to the increasing prevalence of congenital heart disorders, specifically atrial septal defects and ventricular septal defects.
Table of Contents
1. Introduction
1.1. Study Objective
1.2. Scope of the report
1.3. Market Taxonomy
1.2. Scope of the report
1.3. Market Taxonomy
2. Study Assumptions and Abbreviations
2.1. Research Methodology
2.2. Secondary Research
2.3. Primary Research
2.4. SPSS Approach
2.5. Data Triangulation
2.2. Secondary Research
2.3. Primary Research
2.4. SPSS Approach
2.5. Data Triangulation
4. Global Industry Overview Market Overview
4.1. Market Overview
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROTs
4.5. Government Regulation: How they would Aid the Business?
4.6. Competitive Landscape
4.6.1. ARTIVION, INC
4.6.2. Abbott Laboratories
4.6.3. Baxter International.
4.6.4. Collagen Solutions (US) LLC
4.6.5. Edwards Lifesciences Corporation
4.6.6. FOC Medical S.A.
4.6.7. Labcor Laboratórios Ltda
4.6.8. LeMaitre Vascular, Inc.
4.6.9. Visionary Medtech Solutions Pvt. Ltd.
4.6.10. W. L. Gore & Associates, Inc.
4.7. Ongoing Technological Advancements
4.8. Price Benchmarking
4.9. SWOT Analysis
4.10. Unique Selling Proposition (USP)
4.11. Startup Overview
4.12. End user in Pericardial Patches
4.13. Root Cause Analysis
4.14. Business Expansion in Different Region
4.15. Porter’s Five Forces
4.16. Pericardial Patches Utilization in Medical Devices Developed by iVascular
4.17. Key Players in the Market
4.18. Recent Development Analysis
4.19. Industry Risk Assessment
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROTs
4.5. Government Regulation: How they would Aid the Business?
4.6. Competitive Landscape
4.6.1. ARTIVION, INC
4.6.2. Abbott Laboratories
4.6.3. Baxter International.
4.6.4. Collagen Solutions (US) LLC
4.6.5. Edwards Lifesciences Corporation
4.6.6. FOC Medical S.A.
4.6.7. Labcor Laboratórios Ltda
4.6.8. LeMaitre Vascular, Inc.
4.6.9. Visionary Medtech Solutions Pvt. Ltd.
4.6.10. W. L. Gore & Associates, Inc.
4.7. Ongoing Technological Advancements
4.8. Price Benchmarking
4.9. SWOT Analysis
4.10. Unique Selling Proposition (USP)
4.11. Startup Overview
4.12. End user in Pericardial Patches
4.13. Root Cause Analysis
4.14. Business Expansion in Different Region
4.15. Porter’s Five Forces
4.16. Pericardial Patches Utilization in Medical Devices Developed by iVascular
4.17. Key Players in the Market
4.18. Recent Development Analysis
4.19. Industry Risk Assessment
5. Gobal Outlook and Projections
5.1. Global Overview
5.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
5.1.2. Increment $ Opportunity Assessment, 2024-2037
5.1.3. Year-on-Year Growth Forecast (%)
5.2. Global Segmentation (USD Million), 2024-2037, By
5.2.1. Type, Value (USD Million)
5.2.1.1. Synthetic Pericardial Patches
5.2.1.2. Biological Pericardial Patches
5.2.1.2.1. Autologous
5.2.1.2.2. Xenograft
5.2.2. Source, Value (USD Million)
5.2.2.1. Bovine
5.2.2.2. Porcine
5.2.2.3. Equine
5.2.2.4. Others
5.2.3. Application, Value (USD Million)
5.2.3.1. Cardiovascular Surgery
5.2.3.2. Heart Valve Repair
5.2.3.3. Congenital Heart Defects
5.2.3.4. Dental Surgery
5.2.3.5. Others
5.2.4. End user, Value (USD Million)
5.2.4.1. Hospitals
5.2.4.2. Specialty Clinics
5.2.4.3. Ambulatory Surgical Center
5.2.4.4. Research and Academic Institutes
5.2.5. Regional Synopsis (USD Million), 2024-2037
5.2.5.1. North America, Value (USD Million)
5.2.5.2. Europe, Value (USD Million)
5.2.5.3. Asia Pacific, Value (USD Million)
5.2.5.4. Latin America, Value (USD Million)
5.2.5.5. Middle East and Africa, Value (USD Million)
5.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
5.1.2. Increment $ Opportunity Assessment, 2024-2037
5.1.3. Year-on-Year Growth Forecast (%)
5.2. Global Segmentation (USD Million), 2024-2037, By
5.2.1. Type, Value (USD Million)
5.2.1.1. Synthetic Pericardial Patches
5.2.1.2. Biological Pericardial Patches
5.2.1.2.1. Autologous
5.2.1.2.2. Xenograft
5.2.2. Source, Value (USD Million)
5.2.2.1. Bovine
5.2.2.2. Porcine
5.2.2.3. Equine
5.2.2.4. Others
5.2.3. Application, Value (USD Million)
5.2.3.1. Cardiovascular Surgery
5.2.3.2. Heart Valve Repair
5.2.3.3. Congenital Heart Defects
5.2.3.4. Dental Surgery
5.2.3.5. Others
5.2.4. End user, Value (USD Million)
5.2.4.1. Hospitals
5.2.4.2. Specialty Clinics
5.2.4.3. Ambulatory Surgical Center
5.2.4.4. Research and Academic Institutes
5.2.5. Regional Synopsis (USD Million), 2024-2037
5.2.5.1. North America, Value (USD Million)
5.2.5.2. Europe, Value (USD Million)
5.2.5.3. Asia Pacific, Value (USD Million)
5.2.5.4. Latin America, Value (USD Million)
5.2.5.5. Middle East and Africa, Value (USD Million)
6. North America Market
6.1. Overview
6.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.1.2. Increment $ Opportunity Assessment, 2024-2037
6.1.3. Year-on-Year Growth Forecast (%)
6.2. Segmentation (USD Million), 2024-2037, By
6.2.1. Type, Value (USD Million)
6.2.1.1. Synthetic Pericardial Patches
6.2.1.2. Biological Pericardial Patches
6.2.1.2.1. Autologous
6.2.1.2.2. Xenograft
6.2.2. Source, Value (USD Million)
6.2.2.1. Bovine
6.2.2.2. Porcine
6.2.2.3. Equine
6.2.2.4. Others
6.2.3. Application, Value (USD Million)
6.2.3.1. Cardiovascular Surgery
6.2.3.2. Heart Valve Repair
6.2.3.3. Congenital Heart Defects
6.2.3.4. Dental Surgery
6.2.3.5. Others
6.2.4. End user, Value (USD Million)
6.2.4.1. Hospitals
6.2.4.2. Specialty Clinics
6.2.4.3. Ambulatory Surgical Center
6.2.4.4. Research and Academic Institutes
6.2.5. Country Level Analysis, Value (USD Million)
6.2.5.1. U.S.
6.2.5.2. Canada
6.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
6.1.2. Increment $ Opportunity Assessment, 2024-2037
6.1.3. Year-on-Year Growth Forecast (%)
6.2. Segmentation (USD Million), 2024-2037, By
6.2.1. Type, Value (USD Million)
6.2.1.1. Synthetic Pericardial Patches
6.2.1.2. Biological Pericardial Patches
6.2.1.2.1. Autologous
6.2.1.2.2. Xenograft
6.2.2. Source, Value (USD Million)
6.2.2.1. Bovine
6.2.2.2. Porcine
6.2.2.3. Equine
6.2.2.4. Others
6.2.3. Application, Value (USD Million)
6.2.3.1. Cardiovascular Surgery
6.2.3.2. Heart Valve Repair
6.2.3.3. Congenital Heart Defects
6.2.3.4. Dental Surgery
6.2.3.5. Others
6.2.4. End user, Value (USD Million)
6.2.4.1. Hospitals
6.2.4.2. Specialty Clinics
6.2.4.3. Ambulatory Surgical Center
6.2.4.4. Research and Academic Institutes
6.2.5. Country Level Analysis, Value (USD Million)
6.2.5.1. U.S.
6.2.5.2. Canada
7. Europe Market
7.1. Overview
7.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
7.1.2. Increment $ Opportunity Assessment, 2024-2037
7.1.3. Year-on-Year Growth Forecast (%)
7.2. Segmentation (USD Million), 2024-2037, By
7.2.1. Type, Value (USD Million)
7.2.1.1. Synthetic Pericardial Patches
7.2.1.2. Biological Pericardial Patches
7.2.1.2.1. Autologous
7.2.1.2.2. Xenograft
7.2.2. Source, Value (USD Million)
7.2.2.1. Bovine
7.2.2.2. Porcine
7.2.2.3. Equine
7.2.2.4. Others
7.2.3. Application, Value (USD Million)
7.2.3.1. Cardiovascular Surgery
7.2.3.2. Heart Valve Repair
7.2.3.3. Congenital Heart Defects
7.2.3.4. Dental Surgery
7.2.3.5. Others
7.2.4. End user, Value (USD Million)
7.2.4.1. Hospitals
7.2.4.2. Specialty Clinics
7.2.4.3. Ambulatory Surgical Center
7.2.4.4. Research and Academic Institutes
7.2.5. Country Level Analysis, Value (USD Million)
7.2.5.1. UK
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. NORDIC
7.2.5.7. Russia
7.2.5.8. Rest of Europe
7.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
7.1.2. Increment $ Opportunity Assessment, 2024-2037
7.1.3. Year-on-Year Growth Forecast (%)
7.2. Segmentation (USD Million), 2024-2037, By
7.2.1. Type, Value (USD Million)
7.2.1.1. Synthetic Pericardial Patches
7.2.1.2. Biological Pericardial Patches
7.2.1.2.1. Autologous
7.2.1.2.2. Xenograft
7.2.2. Source, Value (USD Million)
7.2.2.1. Bovine
7.2.2.2. Porcine
7.2.2.3. Equine
7.2.2.4. Others
7.2.3. Application, Value (USD Million)
7.2.3.1. Cardiovascular Surgery
7.2.3.2. Heart Valve Repair
7.2.3.3. Congenital Heart Defects
7.2.3.4. Dental Surgery
7.2.3.5. Others
7.2.4. End user, Value (USD Million)
7.2.4.1. Hospitals
7.2.4.2. Specialty Clinics
7.2.4.3. Ambulatory Surgical Center
7.2.4.4. Research and Academic Institutes
7.2.5. Country Level Analysis, Value (USD Million)
7.2.5.1. UK
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. NORDIC
7.2.5.7. Russia
7.2.5.8. Rest of Europe
8. Asia Pacific Market
8.1. Overview
8.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.1.2. Increment $ Opportunity Assessment, 2024-2037
8.1.3. Year-on-Year Growth Forecast (%)
8.2. Segmentation (USD Million), 2024-2037, By
8.2.1. Type, Value (USD Million)
8.2.1.1. Synthetic Pericardial Patches
8.2.1.2. Biological Pericardial Patches
8.2.1.2.1. Autologous
8.2.1.2.2. Xenograft
8.2.2. Source, Value (USD Million)
8.2.2.1. Bovine
8.2.2.2. Porcine
8.2.2.3. Equine
8.2.2.4. Others
8.2.3. Application, Value (USD Million)
8.2.3.1. Cardiovascular Surgery
8.2.3.2. Heart Valve Repair
8.2.3.3. Congenital Heart Defects
8.2.3.4. Dental Surgery
8.2.3.5. Others
8.2.4. End user, Value (USD Million)
8.2.4.1. Hospitals
8.2.4.2. Specialty Clinics
8.2.4.3. Ambulatory Surgical Center
8.2.4.4. Research and Academic Institutes
8.2.5. Country Level Analysis, Value (USD Million)
8.2.5.1. China
8.2.5.1.1. Hong Kong
8.2.5.2. Japan
8.2.5.3. India
8.2.5.4. Australia
8.2.5.5. South Korea
8.2.5.6. Vietnam
8.2.5.7. Thailand
8.2.5.8. Singapore
8.2.5.9. Malaysia
8.2.5.10. Rest of Asia Pacific
8.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
8.1.2. Increment $ Opportunity Assessment, 2024-2037
8.1.3. Year-on-Year Growth Forecast (%)
8.2. Segmentation (USD Million), 2024-2037, By
8.2.1. Type, Value (USD Million)
8.2.1.1. Synthetic Pericardial Patches
8.2.1.2. Biological Pericardial Patches
8.2.1.2.1. Autologous
8.2.1.2.2. Xenograft
8.2.2. Source, Value (USD Million)
8.2.2.1. Bovine
8.2.2.2. Porcine
8.2.2.3. Equine
8.2.2.4. Others
8.2.3. Application, Value (USD Million)
8.2.3.1. Cardiovascular Surgery
8.2.3.2. Heart Valve Repair
8.2.3.3. Congenital Heart Defects
8.2.3.4. Dental Surgery
8.2.3.5. Others
8.2.4. End user, Value (USD Million)
8.2.4.1. Hospitals
8.2.4.2. Specialty Clinics
8.2.4.3. Ambulatory Surgical Center
8.2.4.4. Research and Academic Institutes
8.2.5. Country Level Analysis, Value (USD Million)
8.2.5.1. China
8.2.5.1.1. Hong Kong
8.2.5.2. Japan
8.2.5.3. India
8.2.5.4. Australia
8.2.5.5. South Korea
8.2.5.6. Vietnam
8.2.5.7. Thailand
8.2.5.8. Singapore
8.2.5.9. Malaysia
8.2.5.10. Rest of Asia Pacific
9. Latin America Market
9.1. Global Overview
9.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
9.1.2. Increment $ Opportunity Assessment, 2024-2037
9.1.3. Year-on-Year Growth Forecast (%)
9.2. Global Segmentation (USD Million), By
9.2.1. Type, Value (USD Million)
9.2.1.1. Synthetic Pericardial Patches
9.2.1.2. Biological Pericardial Patches
9.2.1.2.1. Autologous
9.2.1.2.2. Xenograft
9.2.2. Source, Value (USD Million)
9.2.2.1. Bovine
9.2.2.2. Porcine
9.2.2.3. Equine
9.2.2.4. Others
9.2.3. Application, Value (USD Million)
9.2.3.1. Cardiovascular Surgery
9.2.3.2. Heart Valve Repair
9.2.3.3. Congenital Heart Defects
9.2.3.4. Dental Surgery
9.2.3.5. Others
9.2.4. End user, Value (USD Million)
9.2.4.1. Hospitals
9.2.4.2. Specialty Clinics
9.2.4.3. Ambulatory Surgical Center
9.2.4.4. Research and Academic Institutes
9.2.5. Country Level Analysis, Value (USD Million)
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
9.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
9.1.2. Increment $ Opportunity Assessment, 2024-2037
9.1.3. Year-on-Year Growth Forecast (%)
9.2. Global Segmentation (USD Million), By
9.2.1. Type, Value (USD Million)
9.2.1.1. Synthetic Pericardial Patches
9.2.1.2. Biological Pericardial Patches
9.2.1.2.1. Autologous
9.2.1.2.2. Xenograft
9.2.2. Source, Value (USD Million)
9.2.2.1. Bovine
9.2.2.2. Porcine
9.2.2.3. Equine
9.2.2.4. Others
9.2.3. Application, Value (USD Million)
9.2.3.1. Cardiovascular Surgery
9.2.3.2. Heart Valve Repair
9.2.3.3. Congenital Heart Defects
9.2.3.4. Dental Surgery
9.2.3.5. Others
9.2.4. End user, Value (USD Million)
9.2.4.1. Hospitals
9.2.4.2. Specialty Clinics
9.2.4.3. Ambulatory Surgical Center
9.2.4.4. Research and Academic Institutes
9.2.5. Country Level Analysis, Value (USD Million)
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
10. Middle East & Africa Market
10.1. Global Overview
10.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
10.1.2. Increment $ Opportunity Assessment, 2024-2037
10.1.3. Year-on-Year Growth Forecast (%)
10.2. Global Segmentation (USD Million), By
10.2.1. Type, Value (USD Million)
10.2.1.1. Synthetic Pericardial Patches
10.2.1.2. Biological Pericardial Patches
10.2.1.2.1. Autologous
10.2.1.2.2. Xenograft
10.2.2. Source, Value (USD Million)
10.2.2.1. Bovine
10.2.2.2. Porcine
10.2.2.3. Equine
10.2.2.4. Others
10.2.3. Application, Value (USD Million)
10.2.3.1. Cardiovascular Surgery
10.2.3.2. Heart Valve Repair
10.2.3.3. Congenital Heart Defects
10.2.3.4. Dental Surgery
10.2.3.5. Others
10.2.4. End user, Value (USD Million)
10.2.4.1. Hospitals
10.2.4.2. Specialty Clinics
10.2.4.3. Ambulatory Surgical Center
10.2.4.4. Research and Academic Institutes
10.2.5. Country Level Analysis, Value (USD Million)
10.2.5.1. GCC
10.2.5.2. Israel
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
10.1.1. Market Value (USD Million), Current and Future Projections, 2024-2037
10.1.2. Increment $ Opportunity Assessment, 2024-2037
10.1.3. Year-on-Year Growth Forecast (%)
10.2. Global Segmentation (USD Million), By
10.2.1. Type, Value (USD Million)
10.2.1.1. Synthetic Pericardial Patches
10.2.1.2. Biological Pericardial Patches
10.2.1.2.1. Autologous
10.2.1.2.2. Xenograft
10.2.2. Source, Value (USD Million)
10.2.2.1. Bovine
10.2.2.2. Porcine
10.2.2.3. Equine
10.2.2.4. Others
10.2.3. Application, Value (USD Million)
10.2.3.1. Cardiovascular Surgery
10.2.3.2. Heart Valve Repair
10.2.3.3. Congenital Heart Defects
10.2.3.4. Dental Surgery
10.2.3.5. Others
10.2.4. End user, Value (USD Million)
10.2.4.1. Hospitals
10.2.4.2. Specialty Clinics
10.2.4.3. Ambulatory Surgical Center
10.2.4.4. Research and Academic Institutes
10.2.5. Country Level Analysis, Value (USD Million)
10.2.5.1. GCC
10.2.5.2. Israel
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East & Africa
11. Global Economic Scenario
11.1. World Economic Outlook
12. About the Publisher
12.1. Global Clientele
Companies Mentioned
- Edwards Lifesciences Corporation
- Abbott Laboratories
- CryoLife Inc.
- W.L. Gore & Associates
- LeMaitre Vascular.
